Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor - Kubitza, D; Becka, M; Voith, B; Zuehlsdorf, M; Wensing, G (Clin Pharmacol Ther, 2005)